228 related articles for article (PubMed ID: 14612199)
1. Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis.
Kaden JJ; Dempfle CE; Grobholz R; Tran HT; Kiliç R; Sarikoç A; Brueckmann M; Vahl C; Hagl S; Haase KK; Borggrefe M
Atherosclerosis; 2003 Oct; 170(2):205-11. PubMed ID: 14612199
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
4. Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts.
Kaden JJ; Dempfle CE; Kiliç R; Sarikoç A; Hagl S; Lang S; Brueckmann M; Borggrefe M
Exp Mol Pathol; 2005 Feb; 78(1):36-40. PubMed ID: 15596058
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.
Satta J; Oiva J; Salo T; Eriksen H; Ohtonen P; Biancari F; Juvonen TS; Soini Y
Ann Thorac Surg; 2003 Sep; 76(3):681-8; discussion 688. PubMed ID: 12963177
[TBL] [Abstract][Full Text] [Related]
6. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis.
Matilla L; Roncal C; Ibarrola J; Arrieta V; García-Peña A; Fernández-Celis A; Navarro A; Álvarez V; Gainza A; Orbe J; Cachofeiro V; Zalba G; Sádaba R; Rodríguez JA; López-Andrés N
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1370-1382. PubMed ID: 32188274
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
8. Influence of cytokines on matrix metalloproteinases produced by fibroblasts cultured in monolayer and collagen gels.
Wong WR; Kossodo S; Kochevar IE
J Formos Med Assoc; 2001 Jun; 100(6):377-82. PubMed ID: 11480246
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model.
Joghetaei N; Akhyari P; Rauch BH; Cullen P; Lichtenberg A; Rudelius M; Pelisek J; Schmidt R
J Thorac Cardiovasc Surg; 2011 Jul; 142(1):191-8. PubMed ID: 21146836
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase expression in nonrheumatic aortic stenosis.
Edep ME; Shirani J; Wolf P; Brown DL
Cardiovasc Pathol; 2000; 9(5):281-6. PubMed ID: 11064275
[TBL] [Abstract][Full Text] [Related]
12. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
14. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinase-9 Expression in Calcified Human Aortic Valves: A Histopathologic, Immunohistochemical, and Ultrastructural Study.
Perrotta I; Sciangula A; Aquila S; Mazzulla S
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):128-37. PubMed ID: 25390353
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop.
Yamamoto T; Eckes B; Mauch C; Hartmann K; Krieg T
J Immunol; 2000 Jun; 164(12):6174-9. PubMed ID: 10843667
[TBL] [Abstract][Full Text] [Related]
17. Cadherin-11 Overexpression Induces Extracellular Matrix Remodeling and Calcification in Mature Aortic Valves.
Sung DC; Bowen CJ; Vaidya KA; Zhou J; Chapurin N; Recknagel A; Zhou B; Chen J; Kotlikoff M; Butcher JT
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1627-37. PubMed ID: 27312222
[TBL] [Abstract][Full Text] [Related]
18. Pathogenetic role of Chlamydia pneumoniae in calcific aortic stenosis: immunohistochemistry study and review of the literature.
Kaden JJ; Bickelhaupt S; Grobholz R; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2003 Jul; 12(4):447-53. PubMed ID: 12918845
[TBL] [Abstract][Full Text] [Related]
19. Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification.
Aloui S; Zidi W; Ouali S; Guizani I; Hadj-Taieb S; Mourali MS; Feki M; Allal-Elasmi M
Mol Biol Rep; 2018 Dec; 45(6):2135-2143. PubMed ID: 30302620
[TBL] [Abstract][Full Text] [Related]
20. Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases.
Galli D; Manuguerra R; Monaco R; Manotti L; Goldoni M; Becchi G; Carubbi C; Vignali G; Cucurachi N; Gherli T; Nicolini F; Lorusso R; Vitale M; Corradi D
Int J Cardiol; 2017 Feb; 228():364-374. PubMed ID: 27866029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
